Nonprofit targets rare diseases pharma avoids, turning gene therapy into a repeatable procedure
A new nonprofit aims to streamline gene therapy for hard-to-fund conditions, reshaping incentives across biotech and regulators.
By Hessa Al-Faleh·· 3 min